Chadwick Harman
Director de Operaciones en BLUE WATER VENTURES INTERNATIONAL, INC. .
Cargos activos de Chadwick Harman
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BLUE WATER VENTURES INTERNATIONAL, INC. | Director/Miembro de la Junta | - | - |
Director de Operaciones | 12/12/2023 | - | |
Director Ejecutivo | - | 12/12/2023 | |
Presidente | - | 12/12/2023 | |
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Presidente | 12/12/2023 | - |
Historial de carrera de Chadwick Harman
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
President | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorial
Commercial Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BLUE WATER VENTURES INTERNATIONAL, INC. | Commercial Services |
Empresas privadas | 1 |
---|---|
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Chadwick Harman
- Experiencia